Aytu BioPharma, Inc. (AYTU) Q3 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Aytu Biopharma, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT NOTE Transcription provided by Deepgram Request Id: 01a04245-fd7b-7d11-8b84-3a0392eff7e6 Created: 2026-08-27T08:11:24.959Z Duration: 2522.9321 Channels: 1 00:00:00.000 -- 00:00:02.800 Good day. Welcome to the Aytu BioPharma Fiscal 00:00:02.800 -- 00:00:04.160 twenty twenty six 00:00:04.480 -- 00:00:07.440 Q3 Earnings Call. At this time, participants are 00:00:07.440 -- 00:00:09.440 in a listen only mode. A question and 00:00:09.440 -- 00:00:11.360 answer session will follow the formal presentation. 00:00:12.015 -- 00:00:12.735 Please 00:00:17.535 -- 00:00:19.775 note this conference is being recorded. I will 00:00:19.775 -- 00:00:21.455 now turn the conference over to your host, 00:00:21.455 -- 00:00:23.455 Robert Plume, Investor Relations. 00:00:23.695 -- 00:00:26.255 You may begin. Great. Thank you very much 00:00:26.255 -- 00:00:29.590 and good afternoon everyone. As the operator indicated, 00:00:29.590 -- 00:00:31.750 during today's call, we will be discussing Aytu 00:00:31.750 -- 00:00:32.950 BioPharma's 00:00:32.950 -- 00:00:36.710 fiscal twenty twenty six third quarter operational 00:00:36.790 -- 00:00:41.855 and financial results for the period ended 03/31/2026. 00:00:42.335 -- 00:00:44.815 Joining us on today's call is Aytu's Chief 00:00:44.815 -- 00:00:48.895 Executive Officer, Josh Disbrow and Ryan Selhorn, the 00:00:48.895 -- 00:00:51.055 company's Chief Financial Officer. 00:00:51.535 -- 00:00:54.590 At the conclusion of today's prepared remarks, we'll 00:00:54.590 -- 00:00:56.590 open the call for a question and answer 00:00:56.590 -- 00:00:57.309 session. 00:00:57.550 -- 00:00:59.629 I'd like to remind everyone that today's call 00:00:59.629 -- 00:01:02.110 is being recorded. A replay of today's call 00:01:02.110 -- 00:01:04.989 will be availabl...